Erbitux

(Cetuximab)

  • Infusion (IV)
  • Head and neck cancer
  • Locally or regionally advanced squamous cell
  • In combination with radiation therapy. Head and neck cancer
  • Metastatic or recurrent squamous cell
  • As monotherapy
  • In patients who failed prior platinum-based therapy. Head and neck cancer
Back to: Full Site NavigationSkip to: side effects sectionSkip to: What to expect sectionSkip to: Risks and warnings sectionSkip to: Common concerns from users and pharmacists
Skip Upsides & Downsides section. Skip to side effects section.
Coupons and discounts
  • (1) 100ml of 2mg/ml vial
  • Cost for (1) 100ml of 2mg/ml vial of Erbitux (Cetuximab) at pharmacies
Skip side effects section. Skip to What to Expect and Pharmacists Tips section.

Side effect rates for Erbitux (Cetuximab)

0 reports
These are side effects of Erbitux (Cetuximab) reported to the FDA by people taking it, and by doctors and pharmacists.
Filter group. All currently selected
Filter group. All currently selected

Common concerns from people taking Erbitux (Cetuximab)

Final section. Do you want to return to drug navigation?
Pregnancy